1-29. (canceled)
30. An iontophoretic transdermal patch for the delivery of a triptan compound, wherein the patch comprises an anode reservoir and a cathode reservoir, wherein the anode reservoir comprises a polyamine hydrogel formed from a polyamine salt of a polyacrylate copolymer and an organic acid, and a gel forming amount of water;
wherein the polyamine hydrogel further comprises:
about 3% to about 20% of the triptan compound in intimate mixture with the hydrogel, and
optionally one or more additives.
31. The iontophoretic transdermal patch of claim 30, wherein the hydrogel comprises at least about 80% water and about 3.0% to about 5.0% triptan compound.
32. The iontophoretic transdermal patch of claim 30, wherein the hydrogel comprises between about 3% and about 10% polyamine salt.
33. The iontophoretic transdermal patch of claim 30, wherein the hydrogel comprises between about 10% and about 18% polyamine salt.
34. The iontophoretic transdermal patch of claim 30, wherein the polyamine salt is a salt of a methacrylate copolymer.
35. The iontophoretic transdermal patch of claim 30, wherein the methacrylate co-polymer is an alkylated methacrylate copolymer.
36. The iontophoretic transdermal patch of claim 30, wherein the hydrogel comprises about 0.01% to about 1.0% antimicrobial agent.
37. The iontophoretic transdermal patch of claim 30, wherein the organic acid comprises lauric acid, which is present in an amount between about 0.5% and about 7.0%.
38. The iontophoretic transdermal patch of claim 30, wherein the organic acid comprises adipic acid, which is present in an amount between about 0.1% and about 2.0%.
39. The iontophoretic transdermal patch of claim 30, wherein the triptan compound is almotriptan, frovatriptan, eletriptan, zolmitriptan, rizatriptan, sumatriptan, naratriptan, or a pharmaceutically acceptable salt thereof.
40. The iontophoretic transdermal patch of claim 30, wherein the triptan compound is sumatriptan or a salt thereof.
41. The iontophoretic transdermal patch of claim 30, wherein the triptan compound is sumatriptan succinate or sumatriptan hydrochloride.
42. The iontophoretic transdermal patch of claim 30, wherein the patch is capable of administering an effective amount of the triptan compound without substantially affecting skin pH.
43. The iontophoretic transdermal patch of claim 30, wherein the patch is capable of administering an effective amount of the triptan compound without substantially affecting skin temperature.
44. The iontophoretic transdermal patch of claim 30, wherein the hydrogel has a pH of about 3 to about 8.
45. The iontophoretic transdermal patch of claim 44, wherein the hydrogel has a pH of about 5.5 to about 7.
46. The iontophoretic transdermal patch of claim 45, wherein the hydrogel has a pH of about 6.
47. The iontophoretic transdermal patch of claim 30, wherein the anode reservoir further comprises a solubility enhancer, a permeation enhancer, an antimicrobial agent or any combination thereof.
48. The iontophoretic transdermal patch of claim 30, wherein the patch comprises a battery which operates throughout use of the patch.
49. The iontophoretic transdermal patch of claim 30, wherein the patch delivers a desired concentration of the triptan compound in less than one hour.
50. The iontophoretic transdermal patch of claim 30, wherein the anode reservoir consists essentially of a polyamine hydrogel formed from:
a polyamine salt of a polyacrylate copolymer and adipic acid, and
a gel forming amount of water;
wherein the polyamine hydrogel further comprises:
between about 3% and about 10% of a triptan compound in intimate mixture with the hydrogel, and
between about 0.05% and about 0.75% methyl para-hydroxy benzoate.
51. The iontophoretic transdermal patch of claim 30, wherein the organic acid is a fatty acid, a dicarboxylic acid or a mixture thereof.
52. An iontophoretic transdermal patch for the delivery of sumatriptan or a salt thereof, wherein the patch comprises an anode reservoir and a cathode reservoir, wherein the anode reservoir comprises a polyamine hydrogel formed from:
an alkylated methacrylate copolymer,
at least about 80% water,
between about 1.0% and about 5.0% lauric acid, and
between about 0.05% and about 0.75% adipic acid; and
wherein the polyamine hydrogel further comprises:
between about 3% and about 10% sumatriptan or salt thereof in intimate mixture with the hydrogel, and
between about 0.02% and about 0.5% methyl para-hydroxy benzoate.
53. The method of claim 52, wherein sumatriptan or a salt thereof is sumatriptan succinate.
54. An iontophoretic transdermal patch for the delivery of sumatriptan succinate, wherein the patch comprises an anode reservoir and a cathode reservoir, wherein the anode reservoir comprises a polyamine hydrogel formed from:
approximately 84% to about 88% water;
approximately 4.0% to about 7.0% alkylated methacrylate co-polymer;
approximately 1.0% to about 5.0% lauric acid; and
approximately 0.05% to about 0.75% adipic acid;
wherein the polyamine hydrogel further comprises:
approximately 3.0% to about 5.0% sumatriptan succinate in intimate mixture with the hydrogel, and
approximately 0.05% to about 0.75% methyl para-hydroxy benzoate.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A non-transitory computer readable medium comprising instructions which, when executed by one or more hardware processors, causes performance of operations comprising:
receiving, at a first network device in a first network, a multicast message comprising data to be transmitted at least to two or more client devices that have roamed from the first network to a same second network;
determining that at least one client device has roamed from the first network to the second network; and
responsive at least to the determining operation:
forwarding, by the first network device to a second network device in the second network, a single copy of the data for distribution to each of the two or more client devices.
2. The medium of claim 1, wherein the determining operation comprises determining that the at least one client device has roamed away from a particular Virtual Local Area Network (VLAN) identified in the multicast message.
3. The medium of claim 1, wherein the first network comprises devices on a first IP subnet and the second network comprises devices on a second IP subnet different than the first IP subnet.
4. The medium of claim 1, wherein the first network comprises a first subset of devices on a particular IP subnet and the second network comprises a second subset of devices on the same particular IP subnet.
5. The medium of claim 1, wherein the operations further comprise the second network device transmitting the data in a unicast message to each of the two or more client devices.
6. The medium of claim 1, wherein the forwarding operation comprises encrypting the data and forwarding the encrypted data to the second network device.
7. The medium of claim 1, wherein the operations further comprise tagging the data with a particular Virtual Local Area Network (VLAN) identified in the multicast message prior to forwarding the data to the second network device, and wherein the second network device identifies the two or more client devices based on the particular Virtual Local Area Network (VLAN).
8. A system comprising:
a device including at least one hardware processor;
the system being configured to perform operations comprising:
receiving, at a first network device in a first network, a multicast message comprising data to be transmitted at least to two or more client devices that have roamed from the first network to a same second network;
determining that at least one client device has roamed from the first network to the second network; and
responsive at least to the determining operation:
forwarding, by the first network device to a second network device in the second network, a single copy of the data for distribution to each of the two or more client devices.
9. The system of claim 8, wherein the determining operation comprises determining that the at least one client device has roamed away from a particular Virtual Local Area Network (VLAN) identified in the multicast message.
10. The system of claim 8, wherein the first network comprises devices on a first IP subnet and the second network comprises devices on a second IP subnet different than the first IP subnet.
11. The system of claim 8, wherein the first network comprises a first subset of devices on a particular IP subnet and the second network comprises a second subset of devices on the same particular IP subnet.
12. The system of claim 8, wherein the operations further comprise the second network device transmitting the data in a unicast message to each of the two or more client devices.
13. The system of claim 8, wherein the forwarding operation comprises encrypting the data and forwarding the encrypted data to the second network device.
14. The system of claim 8, wherein the operations further comprise tagging the data with a particular Virtual Local Area Network (VLAN) identified in the multicast message prior to forwarding the data to the second network device, and wherein the second network device identifies the two or more client devices based on the particular Virtual Local Area Network (VLAN).
15. A method comprising:
receiving, at a first network device in a first network, a multicast message comprising data to be transmitted at least to two or more client devices that have roamed from the first network to a same second network, the first network device comprising a hardware processor;
determining that at least one client device has roamed from the first network to the second network; and
responsive at least to the determining operation:
forwarding, by the first network device to a second network device in the second network, a single copy of the data for distribution to each of the two or more client devices.
16. The method of claim 15, wherein the determining operation comprises determining that the at least one client device has roamed away from a particular Virtual Local Area Network (VLAN) identified in the multicast message.
17. The method of claim 15, wherein the first network comprises devices on a first IP subnet and the second network comprises devices on a second IP subnet different than the first IP subnet.
18. The method of claim 15, wherein the first network comprises a first subset of devices on a particular IP subnet and the second network comprises a second subset of devices on the same particular IP subnet.
19. The method of claim 15, wherein the operations further comprise the second network device transmitting the data in a unicast message to each of the two or more client devices.
20. The method of claim 15, wherein the forwarding operation comprises encrypting the data and forwarding the encrypted data to the second network device.
21. The method of claim 15, wherein the operations further comprise tagging the data with a particular Virtual Local Area Network (VLAN) identified in the multicast message prior to forwarding the data to the second network device, and wherein the second network device identifies the two or more client devices based on the particular Virtual Local Area Network (VLAN).